Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

from NYT > Technology https://ift.tt/2IpPvlz

Comments

Popular posts from this blog

Prof. M. Ramalinga Raju appointed as Vice Chancellor of JNTU Kakinada

APJAKTU Exam Registration opened - B.Tech (FT,PT) July 2021 (2019 and 2015 scheme)